• Barriers to New Therapy Adoption: Therapeutic Inertia

  • May 6 2024
  • Duración: 3 m
  • Podcast

Barriers to New Therapy Adoption: Therapeutic Inertia

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Send us a Text Message.

    The term therapeutic inertia describes the failure of health care providers to initiate or intensify therapy when it is clearly indicated by established guidelines. The term has largely been applied to the management of blood pressure, blood sugar, and cholesterol, by primary care physicians who recognize the need for their patients to control these conditions but fail to act sufficiently to achieve the guideline recommended therapeutic targets. Despite clearly articulated, evidence-based, clinical guidelines, some physicians fail to translate this knowledge into practice. We believe that therapeutic inertia plays a significant role in delaying the adoption of many new treatments.

    Most practitioners function within a “personal comfort zone” of prescribing behavior, being reluctant to take unnecessary risks with new drugs. There is a natural “learning curve,” where clinicians need to learn the side effect profiles and characteristics of new drugs, as well as to be assured that the drugs perform as promised.

    You can download the full Executive Briefing at: https://tkgpact.com/executive-briefings/

    Or, feel free to email us at Insights@thekinetixgroup.com
    Más Menos
Medicina Alternativa y Complementaria Enfermedades Físicas Hygiene & Healthy Living Ciencias Biológicas
Más Menos

Lo que los oyentes dicen sobre Barriers to New Therapy Adoption: Therapeutic Inertia

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles